PLUVICTO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0078-1217 -
Package NDC
0078-1217-61 -
Application number
NDA215833 -
SPL ID
ade5aa80-b303-470f-8e79-7edea0c4a1bc -
SPL set ID
14908037-2892-4d98-a053-253ce35afb1a -
UNII
G6UF363ECX -
RxCUI
2597057 -
RxCUI
2597060
What the source publishes
- Labeler
- Novartis Pharmaceuticals Corporation
- Active ingredients
- lutetium Lu 177 vipivotide tetraxetan
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "PLUVICTO",
"splId": "ade5aa80-b303-470f-8e79-7edea0c4a1bc",
"labels": [
{
"setId": "14908037-2892-4d98-a053-253ce35afb1a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14908037-2892-4d98-a053-253ce35afb1a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14908037-2892-4d98-a053-253ce35afb1a"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Novartis Pharmaceuticals Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, GLASS in 1 PACKAGE (0078-1217-61) / 7.5 mL in 1 VIAL, GLASS",
"package_ndc": "0078-1217-61",
"identifierStatus": "well-formed",
"marketing_start_date": "20260115"
}
],
"productId": "0078-1217_ade5aa80-b303-470f-8e79-7edea0c4a1bc",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0078-1217",
"deaSchedule": null,
"genericName": "lutetium Lu 177 vipivotide tetraxetan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN",
"strength": "27 mCi/mL"
}
],
"applicationNumber": "NDA215833",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220323",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194017",
"N0000194016"
],
"unii": [
"G6UF363ECX"
],
"rxcui": [
"2597057",
"2597060"
],
"spl_set_id": [
"14908037-2892-4d98-a053-253ce35afb1a"
],
"pharm_class_epc": [
"Radioligand Therapeutic Agent [EPC]"
],
"pharm_class_moa": [
"Radioligand Activity [MoA]"
],
"manufacturer_name": [
"Novartis Pharmaceuticals Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0078-1217_ade5aa80-b303-470f-8e79-7edea0c4a1bc"